再鼎医药（09688）今日盘中大跌5.30%，引发市场关注。这一跌势可能与美国前总统特朗普宣布的最新药价政策有关。
据报道，特朗普计划签署一项行政令，要求美国处方药价格与全球最低价格看齐。他声称这一政策将使美国处方药和药品价格几乎立即下降30%至80%。这一消息对全球制药行业产生了显著影响，日本药品指数周一已下跌3.9%。
作为一家中国生物制药公司，再鼎医药的股价下跌可能反映了投资者对这一政策可能带来的全球药价调整的担忧。如果美国实施这一政策，可能会对包括再鼎医药在内的国际制药公司的定价策略和利润率产生重大影响。尽管具体影响程度还有待观察，但市场似乎已经对这一潜在变化做出了反应。投资者需密切关注这一政策的进一步发展及其对制药行业的影响。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.